Introduction
============

Prostate cancer (PCa) is the most common cancer diagnosed among men in developed countries, and it has become the most common malignant tumor of the urinary system and the fastest growing male malignancy in China ([@ref-26]; [@ref-4]; [@ref-3]). Though the use of prostate-specific antigen screening has improved the detection rate of PCa ([@ref-23]) and reduced the mortality risk of PCa, it did not improve all-cause mortality rates ([@ref-7]; [@ref-18]). The 5-year survival rate for most patients with local or regional PCa is 90%, while for men diagnosed with advanced PCa, the 5-year survival rate is only 30%, and metastasis and recurrence of PCa the leading causes of the death ([@ref-19]; [@ref-1]). Studying the mechanism of invasion and metastasis of PCa is therefore of great significance for improving the prognosis of PCa.

The secreted protein acidic and cysteine rich gene in combination with osteonectin, cwcv and kazal like domains proteoglycan 2 (SPOCK2), also known as testincan-2, is a member of the SPOCK family. This gene encodes a protein that binds to glycosaminoglycans to form part of the extracellular matrix (ECM), which plays an important role in cell invasion and metastasis (<https://www.ncbi.nlm.nih.gov/gene/9806>). It was found that SPOCK2 protein is expressed in the ECM of alveolar cells and that polymorphism of this gene was correlated with human alveolar progression, and it was consequently suggested that *SPOCK2* might be a gene of interest in alveolar dysplasia ([@ref-8]). Another study further found that oligonucleotide polymorphism of the *SPOCK2* gene was also related to the deletion of 16q chromosome in breast cancer ([@ref-13]), which was the first report to describe the correlation between the *SPOCK2* gene and cancer. In addition, [@ref-6] found that abnormal methylation of the *SPOCK2* gene was closely associated with PCa, breast cancer, and colon cancer by screening differential methylation genes, and it was deduced that screening for epigenetic inactivation of *SPOCK2* could be used as a diagnostic marker for PCa ([@ref-21]). This study was the first to highlight the correlation between *SPOCK2* and PCa. In a study of glioma, it was found that *SPOCK1* and *SPOCK3* can inhibit the invasiveness of glioma cells by suppressing membrane-type 1 matrix metalloproteinase (MT1-MMP)-mediated matrix metalloproteinase 2 (MMP2) activation, and that high level of SPOCK2 expression could abrogate the inhibition of MMP2 by *SPOCK1* and *SPOCK3* and increase the invasiveness of glioma cells ([@ref-12], [@ref-11]). In contrast, in a study of PCa, *SPOCK1* promoted tumor growth and metastasis ([@ref-2]), however, the role of the *SPOCK2* gene in PCa remains to be reported. The current study aimed to investigate the role and mechanism of action of *SPOCK2* in the development and progression of PCa.

Materials and Methods
=====================

Tissue sample collection
------------------------

All specimens were obtained from patients hospitalized in the Department of Urology of Shengjing Hospital (Shenyang, China). Specimens were collected from 30 surgical patients with PCa and 20 surgical patients with benign prostate hyperplasia (BPH). Informed consent was obtained from all patients, and agreement was obtained from the Ethics Committee of China Medical University before collecting the samples (2018PS302K). None of the patients had other surgical, endocrine, immunological or metabolic diseases, or had taken any other hormonal medication in the three months prior to surgery.

Cell culture and transfection
-----------------------------

The DU145 and LNCaP cells were purchased from the Shanghai Institute of Cell Biology of the Chinese Academy of Sciences (Shanghai, China). The cells were cultured in RPMI-1640 medium supplemented with 10% fetal bovine serum (FBS), in a sterile incubator at 37 °C under 5% CO~2~.

The *SPOCK2* recombinant fragment and the adenoviral vector were purchased from Gene Pharma (Shanghai, China). The transfection was performed according to the manufacturer's instructions. Mock transfected cells were used as negative controls; cells transfected with empty vector were used as vector controls. At 48 h after transfection, the supernatant was discarded and replaced with complete medium and the cells cultured for another 24 h at 37 °C under 5% CO~2~ for further study.

Detection of *SPOCK2* mRNA expression in tissue and cells by real-time PCR
--------------------------------------------------------------------------

Total RNA was obtained from tissue and cells using TRIzol reagent (BioTeke, Beijing, China). All procedures were performed under RNAase free conditions according to the manufacturer's instructions. After quantification of RNA, the expression of *SPOCK2* messenger ribonucleic acid (mRNA) was detected by real-time polymerase chain reaction (PCR). Primer information is shown in [Table 1](#table-1){ref-type="table"}. The reaction conditions were as follows: incubation at 94 °C for 5 min, 40 cycles of incubation at 94 °C for 10 s, 60 °C for 20 s and 72 °C for 30 s. Data were analyzed using the 2^−ΔΔCT^ method. Each sample was assayed in triplicate.
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###### The primers of SPOCK2 for Real-time PCR.
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  Name        Sequence                    Tm     Product length
  ----------- --------------------------- ------ ----------------
  SPOCK2 F    ATGGAGGACGAGCAATGGCT        61.8   93
  SPOCK2 R    TGGGTCGGACGAGGGAAC          60.8   
  β-actin F   CTTAGTTGCGTTACACCCTTTCTTG   62     156
  β-actin R   CTGTCACCTTCACCGTTCCAGTTT    64.4   

Detection of SPOCK2, MT1-MMP and MMP2 protein expression in cells by WB
-----------------------------------------------------------------------

Cells were harvested for 48 h after transfection. Radioimmunoprecipitation assay buffer was added to the samples and the samples placed on ice for 5 min. The samples were then centrifuged at 12,000 rpm, 4 °C for 10 min and the supernatant removed to obtain total protein. After total protein was quantified, sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) was carried out at 80V for 2.5 h. After being blocked for 1 h with 5% skim milk, the membranes were incubated with specific primary antibodies overnight at 4 °C followed by incubation with the secondary antibodies for 2 h at room temperature. The anti-SPOCK2 polyclonal antibody (1:200) was purchased from Santa Cruz, CA, USA, the anti-MT1-MMP (1:1,000) was purchased from Proteintech, Wuhan, China, and the anti-MMP2 (1:500) was purchased from Wanleibio, Shenyang, China. Secondary antibody (1:5,000) was purchased from Wanleibio, Shenyang, China. The film was scanned, and the optical density value of the target strip analyzed using a gel image processing system (Gel-Pro-Analyzer software). All assays were performed in triplicate.

Detection of cell invasion by transwell chamber
-----------------------------------------------

Matrigel was thawed on ice and diluted with serum-free medium. The transwell chamber was coated with 40 μl pre-diluted Matrigel and placed in a 37 °C incubator for 2 h to solidify. The Matrigel-coated transwell chamber was placed in a 24-well plate and 800 μl of medium containing 30% FBS was added to the lower chamber while 200 μl of the cell suspension (2 × 10^4^) was added to the upper chamber. The 24-well plates were incubated at 37 °C under 5% CO~2~ for 26 h at which time cells could be seen in the lower chamber. Cells remaining on the top of the transwell chamber were scraped off with a cotton swab. Invasive cells were fixed with 4% paraformaldehyde for 20 min and stained with 0.5% crystal violet for 5 min; cells in the lower layer of the membrane were counted under an inverted microscope (200×).

Detection of cell migration ability by wound healing assay
----------------------------------------------------------

Cells were transfected in six-well plates and cultured until reaching 90% confluence. A wound was created with a pipette tip, the cells washed twice and cultured in serum-free medium. The wound was observed and photographed at 0 h and 24 h using an inverted microscope (Nikon, Tokyo, Japan). Cell migration ability was described as the number of cells that migrated into the wound. All assays were performed in triplicate.

Detection of MMP2 expression in cells by zymography gel assay
-------------------------------------------------------------

The cell supernatant was obtained after centrifugation. After measuring the concentration, 60 μg protein was used for SDS-PAGE analysis with constant voltage overnight. The gel was then stained in the staining solution for 3 h. After being decolorized, the gel was photographed by a gel imaging system.

Statistical analysis
--------------------

All data are expressed as the mean ± standard deviation (SD) with SPSS version 13.0 software used for the statistical analyses. A Student's *t*-test was used to determine the significance of two group differences. A one-way analysis of variance analysis was used for multiple comparisons. A *P*-value of *P* \< 0.05 (two-tailed) was considered significant.

Results
=======

*SPOCK2* mRNA expression in tissue
----------------------------------

There was no significant difference between the age of the PCa group (69.27 ± 9.15) and the BPH group (66.97 ± 5.95) (*P* \> 0.05). Real-time PCR showed a significantly lower expression of *SPOCK2* in the PCa tissues (2.25 ± 0.38) compared to the BPH tissues (6.12 ± 0.19) (*P* \< 0.05).

*SPOCK2* gene expression after transfection
-------------------------------------------

The recombinant *SPOCK2* fragment was transfected into the DU145 and LNCaP cells by adenovirus, and the *SPOCK2* mRNA level and protein expression in the cells after transfection detected by real-time PCR ([Fig. 1](#fig-1){ref-type="fig"}) and Western Blot (WB) ([Fig. 2](#fig-2){ref-type="fig"}), respectively. The results showed that *SPOCK2* mRNA level and protein expression in DU145 and LNCaP cells after transfection were significantly increased (*P* \< 0.05).

![The *SPOCK2* mRNA expression was measured using RT-PCR.\
(A) The mRNA expression of *SPOCK2* in PCa tissues was significantly lower than that in BPH tissues (\**P* \< 0.05). (B) The mRNA expression of *SPOCK2* in DU145 and LNCaP cells significantly increased after transfection (\**P* \< 0.05).](peerj-07-7163-g001){#fig-1}

![The SPOCK2 protein expression in cells.\
(A) The *SPOCK2* protein expression in DU145 and LNCaP cells was detected via WB. (B) The protein expression of *SPOCK2* in cells significantly increased after transfection (\**P* \< 0.05).](peerj-07-7163-g002){#fig-2}

Effect of *SPOCK2* upregulation on cell invasion
------------------------------------------------

Transwell invasion chamber was used to detect the invasion of DU145 and LNCaP cells after transfection ([Fig. 3](#fig-3){ref-type="fig"}). The results showed that the invasive ability of the transfected group was significantly lower than that of the negative control group and the vector control group (*P* \< 0.05).

![Upregulation of *SPOCK2* on cell invasive ability.\
(A--F) Upregulation of *SPOCK2* on cell invasive ability in DU145 and LNCaP cells following transfection with *SPOCK2* was detected by transwell invasion chamber. (G) The number of DU145 and LNCaP cells migrating into the lower chamber of the transwell invasion chamber was significantly reduced after transfection with *SPOCK2* (\**P* \< 0.05).](peerj-07-7163-g003){#fig-3}

Effect of *SPOCK2* upregulation on cell migration
-------------------------------------------------

The wound healing assay was used to detect the migration ability of DU145 and LNCaP cells after transfection ([Fig. 4](#fig-4){ref-type="fig"}). The results showed that the migration of both DU145 and LNCaP cells was significantly decreased after transfection compared with the negative control group and the vector control group (*P* \< 0.05).

![Upregulation of *SPOCK2* on cell migration.\
(A--L) Upregulation of *SPOCK2* on cell migration following transfection of DU145 and LNCaP cells with *SPOCK2* was detected by the wound healing assay. (B) (M) The wound healing assay showed that cell migration was significantly reduced after transfection with *SPOCK2* (\**P* \< 0.05).](peerj-07-7163-g004){#fig-4}

Effect of *SPOCK2* upregulation on MT1-MMP2 and MMP2 expression
---------------------------------------------------------------

The expression of MT1-MMP2 and MMP2 protein in DU145 and LNCaP cells was detected by WB ([Fig. 5](#fig-5){ref-type="fig"}). The expression of MT1-MMP2 and MMP2 in cells in the transfected group were significantly lower than those in the negative control group and the vector control group (*P* \< 0.05).

![Upregulation of *SPOCK2* on the expression of MT1-MMP and MMP2.\
(A, C) Protein expression of MT1-MMP2 in DU145 and LNCaP cells transfected with *SPOCK2*, via WB, showing a significant decrease in MT1-MMP protein expression following transfection (\**P* \< 0.05). (B, D) Expression of MMP2 in DU145 and LNCaP cells after transfection with *SPOCK2* was significantly decreased (\**P* \< 0.05) as detected via WB.](peerj-07-7163-g005){#fig-5}

Effect of *SPOCK2* upregulation on MMP2 activation
--------------------------------------------------

The expression of activated MMP2 was detected using gelatin zymography after transfection ([Fig. 6](#fig-6){ref-type="fig"}). Expression of activated MMP2 protein after transfection was significantly lower than in the negative control group or the vector control group (*P* \< 0.05).

![Upregulation of *SPOCK2* on the activaion of MMP2.\
(A) Upregulation of SPOCK2 on the activaion of MMP2 was detected by gelatin zymography. (B) Hostogram showed a significant decrease in MMP2 activation in DU145 and LNCaP cells following transfection of these cells with *SPOCK2* (\**P* \< 0.05).](peerj-07-7163-g006){#fig-6}

Discussion
==========

The SPOCK family includes three members, SPOCK1, SPOCK2 and SPOCK3. In 2008, Chung et al. first reported the relationship between SPOCK2 and PCa, colon cancer and breast cancer, by gene screening. The relationship between colon cancer and *SPOCK2* was further verified by [@ref-17], whereby it was found that the incidence of *SPOCK2* methylation in colon cancer was significantly higher than that in adjacent normal mucosa tissues. Another study ([@ref-16]) reported that absence of SPOCK2 expression caused by hypermethylation of the *SPOCK2* gene, may be related to the development and progression of ovarian cancer. The relationship between PCa and the *SPOCK2* gene was not further investigated. In the current study, using real-time PCR, the level of expression of the *SPOCK2* gene was significantly lower in PCa tissues compared to that in BPH tissue, indicating that lower expression of the *SPOCK2* gene may be associated with the tumorigenesis and progression of PCa. To further clarify the role of SPOCK2 in PCa cells, PCa cells were transfected with an adenovirus vector to increase the expression of the *SPOCK2* gene. It was found that upregulation of this gene in PCa cells can inhibit cell invasion and migration. The results indicated the *SPOCK2* may play an important role in the progression of PCa by affecting the migration and invasion ability of the PCa cells. As *SPOCK2* is often inactivated by hypermethylation, a reversible epigenetic change ([@ref-15]), reversal of the expression of the SPOCK2 gene in PCa cells clinically, may improve the prognosis of patients with PCa.

The collagenase, MMP2, can decompose plasma fibronectin and laminin of the basement membrane, and is involved in various physiological and pathological processes in the human body ([@ref-20]; [@ref-24]). The activation of MMP2 is regulated specifically by MT1-MMP, which itself is also capable of degrading a variety of ECM components ([@ref-9]). Both MT1-MMP and MMP2 play an important role in the invasion and migration of PCa ([@ref-22]; [@ref-10]). To explore the mechanism by which SPOCK2 influences the invasion and migration of PCa cells, the expression of MT1-MMP and MMP2, and the activation of MMP2 in PCa cells was investigated using PCa cells with an upregulation of SPOCK2. The results indicated that upregulation of SPOCK2 in PCa cells could inhibit the expression of both MT1-MMP and MMP2 and decrease MMP2 activation. Together, the findings of the present study suggest that SPOCK2 may inhibit the invasion and migration of PCa cells by affecting MT1-MMP/MMP2 expression and activation. In a study of glioma, it was found that SPOCK1 and SPOCK3 could inhibit MT1-MMP-mediated MMP2 activation and inhibit glioma cell invasion by binding to MT1-MMP ([@ref-12]). In contrast, high levels of SPOCK2 could abrogate this inhibition of MMP2 by SPOCK3 and increase the invasiveness of glioma cells ([@ref-11]). In addition, in a study of gastric cancer, SPOCK1 was found to promote the invasion and metastasis of gastric cancer through Slug-induced epithelial-mesenchymal transition ([@ref-5]), and knockdown of SPOCK1 in colorectal cancer could inhibit proliferation and invasion of cancer cells by suppressing the PI3K/Akt Pathway ([@ref-25]). These studies indicate that the effect of SPOCK2 on MT1-MMP/MMP2 in PCa cells may not work by directly binding to the MT1-MMP as the competitive inhibitor of SPOCK1 or SPOCK3. It is very possible that there may be other mechanisms by which SPOCK2 can affect the MT1-MMP/MMP pathway, which requires further investigation.

Conclusions
===========

In conclusion, the present study demonstrates that *SPOCK2* is associated with the progression of PCa, and that upregulation of *SPOCK2* can inhibit PCa cell invasion and metastasis. This is achieved ultimately by its ability to decrease *MT1-MMP* and *MMP2* gene expression and decrease activation of MMP2 protein.
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###### Raw data for Real-time PCR.

Raw data of Real-time PCR for data analyses and preparation for [Fig. 1](#fig-1){ref-type="fig"}

###### 

Click here for additional data file.
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###### Raw data for Western Blot.

Raw data of Western Blot for data analyses and preparation for [Fig. 2](#fig-2){ref-type="fig"} and [Fig. 5](#fig-5){ref-type="fig"}

###### 

Click here for additional data file.
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###### Full-length uncropped blots for [Fig. 2](#fig-2){ref-type="fig"}.

The upper line: SPOCK2 expression for DU145 control, DU145 vector control, DU145 SPOCK2, LNCaP control, LNCaP vector, and LNCaP SPOCK2, respectively. The lower line: β-actin expression for DU145 Control, DU145 vector control, DU145 SPOCK2, LNCaP control, LNCaP vector, and LNCaP SPOCK2, respectively.

###### 

Click here for additional data file.
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###### Full-length uncropped blots for [Fig. 5A](#fig-5){ref-type="fig"}.

The upper line: MT1-MMP expression for DU145 control, DU145 vector control, DU145 SPOCK2, LNCaP control, LNCaP vector, and LNCaP SPOCK2, respectively. The lower line: β-actin expression for DU145 Control, DU145 vector control, DU145 SPOCK2, LNCaP control, LNCaP vector, and LNCaP SPOCK2, respectively.

###### 

Click here for additional data file.
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###### Full-length uncropped blots for [Fig. 5B](#fig-5){ref-type="fig"}.

The upper line: MMP2 expression for DU145 control, DU145 vector control, DU145 SPOCK2, LNCaP control, LNCaP vector, and LNCaP SPOCK2, respectively. The lower line: β-actin expression for DU145 Control, DU145 vector control, DU145 SPOCK2, LNCaP control, LNCaP vector, and LNCaP SPOCK2, respectively.

###### 

Click here for additional data file.
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###### Full-length uncropped blots for [Fig. 6](#fig-6){ref-type="fig"}.

The upper line: MMP2 expression in cells by zymography gel assay for DU145 control, DU145 vector control, DU145 SPOCK2, LNCaP control, LNCaP vector, and LNCaP SPOCK2, respectively. The lower line: MMP9 expression in cells by zymography gel assay for DU145 control, DU145 vector control, DU145 SPOCK2, LNCaP control, LNCaP vector, and LNCaP SPOCK2, respectively.

###### 

Click here for additional data file.
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